Commentary

Drug interaction myths


 

In a study of men taking both tamsulosin and vardenafil or tamsulosin and placebo for the treatment of BPH symptoms, Dr. Mauro Gacci and his colleagues found no significant difference in adverse effects in patients who received tamsulosin plus placebo, compared with men who received tamsulosin plus vardenafil.11

I think it is safe to prescribe triptans in patients who are on SSRIs and SNRIs. In patients who need both alpha-blockers and phosphodiesterase inhibitors, I think tamsulosin is the safest alpha-blocker option. It is best to not start a phosphodiesterase inhibitor at the same time as an alpha-blocker. The studies on coadministration of alpha-blockers and phosphodiesterase inhibitors have been done in either healthy volunteers, or in patients without severe systemic disease. So, the effect on blood pressure in patients taking multiple antihypertensive drugs or heart failure drugs is unknown.

References

1. U.S. Food and Drug Administration. Information for healthcare professionals: Selective serotonin reuptake inhibitors (SSRIs), selective serotonin-norepinephrine reuptake inhibitors (SNRIs), 5-hydroxytryptamine receptor agonists (triptans), July 19, 2006.

2. MedGenMed. 2007 Sep 5;9(3):48.

3. QJM. 2003 Sep;96(9):635-42.

4. Am J Psychiatry. 1991 Jun;148(6):705-13.

5. Cephalalgia. 1999 Sep;19(7):668-75.

6. Headache. 2012 Feb;52(2):198-203.

7. Headache. 2012 Feb;52(2):195-7.

8. Headache. 2010 Jun;50(6):1089-99.

9. J Clin Pharmacol. 2007 Oct;47(10):1303-10.

10. J Urol. 2004 Nov;172(5 Pt 1):1935-40.

11. J Sex Med. 2012 Jun;9(6):1624-33.

Dr. Paauw is professor of medicine in the division of general internal medicine at the University of Washington, Seattle, and he serves as third-year medical student clerkship director at the University of Washington. Contact Dr. Paauw at dpaauw@uw.edu.

Pages

Recommended Reading

Primary care endures in heart failure management
MDedge Cardiology
AACE: New algorithm stresses lifestyle modification in type 2 diabetes
MDedge Cardiology
Chlorthalidone controls blood pressure longer than HCTZ
MDedge Cardiology
Pediatric BMI increases linked to rises in blood pressure, hypertension risk
MDedge Cardiology
Cardiovascular abnormalities persist after preeclamptic pregnancy
MDedge Cardiology
Hypertension metrics controversial in Core Quality Measures Collaborative
MDedge Cardiology
Loss of pulmonary vascular distensibility precedes PH
MDedge Cardiology
In newly diagnosed hypertension with OSA, adding CPAP augmented the benefits of losartan
MDedge Cardiology
No LIGHT shed on CV safety of naltrexone-bupropion
MDedge Cardiology
CV health may prevent cognitive decline
MDedge Cardiology